Literature DB >> 21093424

Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions.

Li Xie1, Tingting Wang, Shaorong Yu, Xi Chen, Lifeng Wang, Xiaoping Qian, Lixia Yu, Yitao Ding, Chenyu Zhang, Baorui Liu.   

Abstract

OBJECTIVES: The study was trying to figure out the possible role of cell-free miR-24 and miR-30d as diagnostic biomarkers for malignant effusions.
METHODS: A total of 110 effusion samples (28 benign and 82 malignant) were collected and cell-free total RNA was extracted. Quantitative RT-PCR was carried out to measure the expression levels of miR-24 and miR-30d, with an exogenous supplemented plant miRNA, ath-miR156a as the reference RNA.
RESULTS: Malignant pleural effusions had higher expression levels of cell-free miR-24 and miR-30d than benign effusions. In the ascites group, only miR-30d was found to be significantly up-regulated in the supernatant of effusions. Combination of cell-free miR-24 and miR-30d could discriminate malignant ascites from benign with improved potency comparing to single miR-30d.
CONCLUSIONS: Cell-free miR-30d and miR-24 are potential diagnostic biomarkers for malignant and benign effusions.
Copyright © 2010 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093424     DOI: 10.1016/j.clinbiochem.2010.11.002

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  11 in total

1.  Microarray expression profile and analysis of circular RNA regulatory network in malignant pleural effusion.

Authors:  Yakun Wen; Yong Wang; Zhenchuan Xing; Zongjian Liu; Ziliang Hou
Journal:  Cell Cycle       Date:  2018-12-27       Impact factor: 4.534

Review 2.  Versatile role of miR-24/24-1*/24-2* expression in cancer and other human diseases.

Authors:  Sanjukta Mukherjee; Bhagyashree Shelar; Sudhir Krishna
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

3.  Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer.

Authors:  Tingting Wang; Mingming Lv; Sunan Shen; Sheng Zhou; Ping Wang; Yueqiu Chen; Baorui Liu; Like Yu; Yayi Hou
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

4.  Diagnostic Value of Circulating Extracellular miR-134, miR-185, and miR-22 Levels in Lung Adenocarcinoma-Associated Malignant Pleural Effusion.

Authors:  Yoon Mi Shin; Jieun Yun; Ok-Jun Lee; Hye-Suk Han; Sung-Nam Lim; Jin Young An; Ki Hyeong Lee; Ki Man Lee; Kang Hyeon Choe
Journal:  Cancer Res Treat       Date:  2014-04-22       Impact factor: 4.679

5.  Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4α miR122 Pathway.

Authors:  Shengnan Wei; Ming Zhang; Yang Yu; Xiaoxin Lan; Fan Yao; Xin Yan; Li Chen; Grant M Hatch
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

6.  Multitargeting activity of miR-24 inhibits long-term melatonin anticancer effects.

Authors:  Federica Mori; Maria Ferraiuolo; Raffaela Santoro; Andrea Sacconi; Frauke Goeman; Matteo Pallocca; Claudio Pulito; Etleva Korita; Maurizio Fanciulli; Paola Muti; Giovanni Blandino; Sabrina Strano
Journal:  Oncotarget       Date:  2016-04-12

7.  Identification of suitable reference genes for the relative quantification of microRNAs in pleural effusion.

Authors:  Hye-Suk Han; Yeong Nang Jo; Jin Yong Lee; Song-Yi Choi; Yusook Jeong; Jieun Yun; Ok-Jun Lee
Journal:  Oncol Lett       Date:  2014-08-01       Impact factor: 2.967

8.  Tumor suppressor miR-24 restrains gastric cancer progression by downregulating RegIV.

Authors:  Yantao Duan; Lei Hu; Bing Liu; Beiqin Yu; Jianfang Li; Min Yan; Yingyan Yu; Chen Li; Liping Su; Zhenggang Zhu; Ming Xiang; Bingya Liu; Qiumeng Yang
Journal:  Mol Cancer       Date:  2014-05-28       Impact factor: 27.401

9.  The gain and loss of long noncoding RNA associated-competing endogenous RNAs in prostate cancer.

Authors:  Dianming Liu; Xuexin Yu; Shuyuan Wang; Enyu Dai; Leiming Jiang; Jing Wang; Qian Yang; Feng Yang; Shunheng Zhou; Wei Jiang
Journal:  Oncotarget       Date:  2016-08-30

10.  MiRNA-575 suppresses angiogenesis by targeting Rab5-MEK-ERK pathway in endothelial cells.

Authors:  Xin Zhao; Yaping Yi; Chao Meng; Ningyuan Fang
Journal:  Biosci Rep       Date:  2019-01-08       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.